TRDA insider buying and SEC filings, explained
Entrada Therapeutics, Inc. · CIK 1689375
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$1.6M
Insiders who bought
2
Sold (not marked 10b5-1)
$13.8M
Planned sales (10b5-1)
$1.3M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 4–9, 2026 | Sale | MPM BIOVENTURES 2018, L.P. (10% owner) sold 259,837 shares indirectly between Sep 4 and Sep 9 at about $7.33 ($1.9M). Indirect holdings down 6% to 3,885,115 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 2 other reporting owners. | SEC filing Filed Sep 9, 2026 |
| Sep 4–9, 2026 | Sale | Ansbert Gadicke (10% owner) sold 259,837 shares indirectly between Sep 4 and Sep 9 at about $7.33 ($1.9M). Indirect holdings down 6% to 3,885,115 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 9 other reporting owners. | SEC filing Filed Sep 9, 2026 |
| Sep 1–3, 2026 | Sale | MPM BIOVENTURES 2018, L.P. (10% owner) sold 86,482 shares indirectly between Sep 1 and Sep 3 at about $7.14 ($617K). Indirect holdings down 2% to 4,144,952 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 2 other reporting owners. | SEC filing Filed Sep 3, 2026 |
| Sep 1–3, 2026 | Sale | Ansbert Gadicke (10% owner) sold 86,482 shares indirectly between Sep 1 and Sep 3 at about $7.14 ($617K). Indirect holdings down 2% to 4,144,952 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 9 other reporting owners. | SEC filing Filed Sep 3, 2026 |
| Aug 27–31, 2026 | Sale | MPM BIOVENTURES 2018, L.P. (10% owner) sold 86,914 shares indirectly between Aug 27 and Aug 31 at about $7.08 ($616K). Indirect holdings down 2% to 4,231,434 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 2 other reporting owners. | SEC filing Filed Aug 31, 2026 |
| Aug 27–31, 2026 | Sale | Ansbert Gadicke (10% owner) sold 86,914 shares indirectly between Aug 27 and Aug 31 at about $7.08 ($616K). Indirect holdings down 2% to 4,231,434 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 9 other reporting owners. | SEC filing Filed Aug 31, 2026 |
| Aug 24–26, 2026 | Sale | Ansbert Gadicke (10% owner) sold 62,714 shares indirectly between Aug 24 and Aug 26 at about $7.36 ($462K). Indirect holdings down 1% to 4,318,348 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 9 other reporting owners. | SEC filing Filed Aug 26, 2026 |
| Aug 24–26, 2026 | Sale | MPM BIOVENTURES 2018, L.P. (10% owner) sold 62,714 shares indirectly between Aug 24 and Aug 26 at about $7.36 ($462K). Indirect holdings down 1% to 4,318,348 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 2 other reporting owners. | SEC filing Filed Aug 26, 2026 |
| Aug 6–10, 2026 | Sale | Kush Parmar (Director) sold 155,255 shares indirectly (by entity) between Aug 6 and Aug 10 at about $6.95 ($1.1M). Holdings by entity down 5% to 2,691,337 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 10, 2026 |
| Aug 6–7, 2026 | Sale | Scott M. Rocklage (10% owner) sold 62,811 shares between Aug 6 and Aug 7 at about $6.88 ($432K). Holdings down 2% to 2,783,781 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 5 other reporting owners. | SEC filing Filed Aug 10, 2026 |
| Jul 30–31, 2026 | Sale | Kush Parmar (Director and 10% owner) sold 116,474 shares indirectly (by entity) between Jul 30 and Jul 31 at about $6.93 ($807K). Holdings by entity down 4% to 2,846,592 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 3, 2026 |
| Jul 30–31, 2026 | Sale | Scott M. Rocklage (10% owner) sold 116,474 shares between Jul 30 and Jul 31 at about $6.93 ($807K). Holdings down 4% to 2,846,592 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 5 other reporting owners. | SEC filing Filed Aug 3, 2026 |
| May 20, 2026 | Purchase (code P) | Bernhardt G Zeiher (Director) bought 5,000 shares indirectly (by trust) at about $5.86 ($29K), reported as a purchase (code P). New position of 5,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 21, 2026 |
| May 4, 2026 | Planned (10b5-1) | Natarajan Sethuraman (President / COO) sold 25,907 shares at about $15.39 ($399K), marked as a 10b5-1 plan trade. Holdings down 11% to 216,317 shares. | SEC filing Filed May 4, 2026 |
| May 4, 2026 | Planned (10b5-1) | Nathan J Dowden (President / COO) sold 15,000 shares at about $15.33 ($230K), marked as a 10b5-1 plan trade. Holdings down 7% to 198,588 shares. | SEC filing Filed May 4, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Kory James Wentworth (CFO) sold 2,500 shares at $12.95 ($32K), marked as a 10b5-1 plan trade. Holdings down 2% to 119,010 shares. | SEC filing Filed Apr 2, 2026 |
| Mar 9–10, 2026 | Planned (10b5-1) | Nathan J Dowden (President / COO) sold 15,010 shares between Mar 9 and Mar 10 at about $13.04 ($196K), marked as a 10b5-1 plan trade. Holdings down 7% to 198,588 shares. | SEC filing Filed Mar 11, 2026 |
| Mar 9–10, 2026 | Planned (10b5-1) | Kory James Wentworth (CFO) sold 16,477 shares between Mar 9 and Mar 10 at about $13.01 ($214K), marked as a 10b5-1 plan trade. Holdings down 12% to 121,510 shares. | SEC filing Filed Mar 11, 2026 |
| Mar 4, 2026 | Planned (10b5-1) | Kory James Wentworth (CFO) sold 7,988 shares at about $12.25 ($98K), marked as a 10b5-1 plan trade. Holdings down 5% to 137,987 shares. | SEC filing Filed Mar 6, 2026 |
| Nov 21, 2025 | Planned (10b5-1) | Kory James Wentworth (CFO) sold 8,910 shares at about $9.98 ($89K), marked as a 10b5-1 plan trade. Holdings down 7% to 110,026 shares. | SEC filing Filed Nov 24, 2025 |
| Nov 20, 2025 | Purchase (code P) | Julian Baker (10% owner) bought 28,867 shares indirectly at about $9.07 ($262K), reported as a purchase (code P). Indirect holdings up 1% to 4,691,392 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 3 other reporting owners. | SEC filing Filed Nov 24, 2025 |
| Nov 14, 2025 | Sale | Kush Parmar (Director and 10% owner) sold 200,000 shares indirectly (by entity) at about $8.80 ($1.8M). Holdings by entity down 6% to 2,963,066 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 18, 2025 |
| Nov 14, 2025 | Sale | Scott M. Rocklage (10% owner) sold 200,000 shares at about $8.80 ($1.8M). Holdings down 6% to 2,963,066 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 5 other reporting owners. | SEC filing Filed Nov 18, 2025 |
| Nov 10–12, 2025 | Purchase (code P) | Julian Baker (10% owner) bought 178,044 shares indirectly between Nov 10, 2025 and Nov 12, 2025 at about $7.60 ($1.4M), reported as a purchase (code P). Indirect holdings up 4% to 4,664,924 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 3 other reporting owners. | SEC filing Filed Nov 12, 2025 |
15 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow TRDA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.